How A CDMO Can Increase The Competitiveness Of Your Product

By Alan Huang, Sr. Manager, Supply Chain Management, Bora Pharmaceuticals, Zhunan Site

After 1990, the pharmaceutical industry shifted due to increased R&D spending, changes in the health insurance system, and the competition from new drugs and ones that were going generic. This shift drove increased complexity in supply chain operations. The demand for smaller production scale and shorter fulfillment times have been increasing. In some cases, this situation caused changes in product prices, regulatory uncertainty around new product development, and some inefficient collaborations in the supply chain operations.

What Is the Current Challenge?

Pharmaceutical companies continue to look for cost efficiencies due to these changes. Simple manufacturing outsourcing services no longer meet the financial and environmental protection requirements of pharmaceutical companies.